Switch Language
Alt tag
Bayer Logo Bayer Logo Bayer Logo

Bienvenido a Thrombosis Adviser

Información sobre trombosis venosa y arterial destinada

Artículos seleccionados

Bayer symposium highlights from the ESC congress 2021
Bayer symposium highlights from the ESC congress 2021
Ensuring protection for patients with cancer-associated thrombosis
Ensuring protection for patients with cancer-associated thrombosis
Protecting vulnerable patients with VTE: Choose a guideline-recommended therapy that has been thoroughly tested
Protecting vulnerable patients with VTE: Choose a guideline-recommended therapy that has been thoroughly tested
Patient preference: How can it help to reduce the burden of thrombosis in patients with cancer-associated thrombosis?
Patient preference: How can it help to reduce the burden of thrombosis in patients with cancer-associated thrombosis?

Escuche la serie de podcasts Thrombosis Adviser en inglés

Going one step further: Renal preservation in patients with artial fibrillation 

Find out why renal decline is an important issue for patients with AF and how they can be protected

Approval code: PP-M_RIV-ALL-0104-1

Check out our story
Renal preservation

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!

Aspirina, EINSTEIN
CHOICE y tratamiento
de TEV a largo plazo

YYMMDD Author/Uploaded by

El profesor Paolo Prandoni analiza el papel del AAS en el tratamiento prolongado del TEV y analiza el reciente estudio EINSTEIN CHOICE, que comparó dos dosis de rivaroxabán con AAS para el tratamiento prolongado del TEV

N.º de autorización PP-XAR-ALL-1747-1

Artículos seleccionados

Study teaser image
ThrombosisAdviser at the European Society of Cardiology Congress 2019: Focus on Atrial Fibrillation
Study teaser image
Paediatric patients with VTE: Protecting the most challenging population
Study teaser image
Thrombosis Adviser at the European Society of Cardiology Congress 2019
Study teaser image
Making connections: Stroke risk in patients with multiple co-morbidities

Latest in Thrombosis

ThrombosisAdviser at
the European Society of
Cardiology Congress 2019

The European Society of Cardiology (ESC) congress is the largest cardio-vascular congress in the world. This year’s event also included the World Congress of Cardiology and attracted over 30,000 delegates, who gathered at the Paris Expo Porte de Versailles to participate in a programme of over 500 different sessions across the full spectrum of cardiovascular medicine. As ever, a large amount of the data and discussion focused on prevention of stroke in patients with atrial fibrillation (AF), reflecting the huge burden of this disease around the world.

Ver todo
Alt tag

Latest Video

Aspirina, EINSTEIN
CHOICE y tratamiento
de TEV a largo plazo

YYMMDD Author/Uploaded by

El profesor Paolo Prandoni analiza el papel del AAS en el tratamiento prolongado del TEV y analiza el reciente estudio EINSTEIN CHOICE, que comparó dos dosis de rivaroxabán con AAS para el tratamiento prolongado del TEV

N.º de autorización PP-XAR-ALL-1747-1

Únase a la conversación

Thrombosis Connection es un foro de profesionales sanitarios destinado a compartir, crear y fomentar soluciones innovadoras en el campo de la trombosis.

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!